01 / PSC Market Profile
PSC AN95 R&D- Medical: Other (Operational Systems Development) Federal Contracts
Product and Service Code AN95
Federal contract activity classified under R&D- Medical: Other (Operational Systems Development) across FY 2019–FY 2025. Net obligations include both new obligations and subsequent deobligations.
02 / Market Size
How large is the PSC AN95 federal market?
03 / Spending Trend
PSC AN95 contract spending by fiscal year
Annual obligations, activity, and participation across the same FY 2019–FY 2025 profile window.
| Fiscal year | Obligations | Actions | Vendors | Customers | Change |
|---|---|---|---|---|---|
| FY 2019 | $2.85M | 29 | 17 | 2 | — |
| FY 2020 | $3.59M | 24 | 13 | 2 | +26.1% |
| FY 2021 | -$1.09M | 15 | 9 | 4 | −130.3% |
| FY 2022 | $1.09M | 6 | 3 | 2 | +200.5% |
| FY 2023 | $5.50M | 3 | 1 | 2 | +402.9% |
| FY 2024 | $1.32M | 3 | 3 | 3 | −76.0% |
| FY 2025 | $475.4K | 5 | 3 | 2 | −64.0% |
04 / Top Federal Customers
Which federal agencies buy most in this industry?
Ranked by net obligations during FY 2019–FY 2025.
| Federal customer | Code | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|
| DEPT OF THE ARMY | 2100 | $6.43M | 65 | 22 | 46.8% |
| DEFENSE HEALTH AGENCY (DHA) | 97DH | $6.39M | 7 | 2 | 46.5% |
| DEPT OF THE AIR FORCE | 5700 | $1.01M | 4 | 1 | 7.4% |
| DEFENSE CONTRACT MANAGEMENT AGENCY (DCMA) | 9763 | -$18.4K | 2 | 1 | -0.1% |
| CENTERS FOR DISEASE CONTROL AND PREVENTION | 7523 | -$35.8K | 5 | 2 | -0.3% |
| DEPT OF THE NAVY | 1700 | -$40.0K | 2 | 1 | -0.3% |
05 / Contracting Offices
Which contracting offices buy in PSC AN95?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|---|
| ARMY MED RES ACQ ACTIVITY | HT9425 | DEFENSE HEALTH AGENCY (DHA) | $6.39M | 7 | 2 | 46.5% |
| W4PZ USA MED RSCH ACQUIS ACT | W81XWH | DEPT OF THE ARMY | $5.94M | 60 | 19 | 43.2% |
| FA8003 771 ENTERPRISE SOURCING SQ | FA8003 | DEPT OF THE AIR FORCE | $1.01M | 4 | 1 | 7.4% |
| W6QK ACC-APG NATICK | W911QY | DEPT OF THE ARMY | $494.2K | 5 | 3 | 3.6% |
| HQ DEF CONTRACT MANAGEMENT AGENCY | S5102A | DEFENSE CONTRACT MANAGEMENT AGENCY (DCMA) | $0 | 1 | 1 | 0.0% |
| DCMA MID-ATLANTIC | S2404A | DEFENSE CONTRACT MANAGEMENT AGENCY (DCMA) | -$18.4K | 1 | 1 | -0.1% |
| CDC OFFICE OF ACQUISITION SERVICES | 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | -$35.8K | 5 | 2 | -0.3% |
| NAVAL MEDICAL RESEARCH CENTER | N32398 | DEPT OF THE NAVY | -$40.0K | 2 | 1 | -0.3% |
06 / Top Vendors
Which contractors lead the PSC AN95 market?
| Vendor | Obligations | Actions | Customers | Market share | Latest activity |
|---|---|---|---|---|---|
| VASCULAR SOLUTIONS LLC | $9.74M | 14 | 2 | 70.9% | Sep 8, 2025 |
| SENECA TELECOMMUNICATIONS, LLC | $1.51M | 7 | 2 | 11.0% | Nov 18, 2021 |
| LAULIMA GOVERNMENT SOLUTIONS, LLC | $1.31M | 12 | 1 | 9.5% | Apr 22, 2021 |
| TEVA PHARMACEUTICALS USA, INC. | $928.8K | 2 | 2 | 6.8% | Jan 22, 2025 |
| IQVIA GOVERNMENT SOLUTIONS INC | $393.8K | 5 | 1 | 2.9% | Feb 18, 2021 |
| SA PHOTONICS, INC. | $332.7K | 3 | 1 | 2.4% | Jan 10, 2025 |
| BMK VENTURES, INC. | $319.0K | 1 | 1 | 2.3% | Sep 18, 2020 |
| SCHMITT CONSULTING SERVICES, INC. | $26.5K | 1 | 1 | 0.2% | Sep 10, 2019 |
| REMOTE DIAGNOSTIC TECHNOLOGIES LIMITED | $6.7K | 2 | 1 | 0.0% | Apr 14, 2021 |
| GENEVA FOUNDATION, THE | $0 | 1 | 1 | 0.0% | Jan 17, 2019 |
07 / Industry Mix
What industries are purchased under PSC AN95?
| NAICS | Description | Obligations | Actions | Vendors | Share |
|---|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $9.74M | 14 | 1 | 70.9% |
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | $1.71M | 21 | 8 | 12.5% |
| 541512 | COMPUTER SYSTEMS DESIGN SERVICES | $1.30M | 13 | 2 | 9.5% |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $928.8K | 2 | 1 | 6.8% |
| 541519 | OTHER COMPUTER RELATED SERVICES | $393.8K | 5 | 1 | 2.9% |
| 334510 | ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS MANUFACTURING | $318.7K | 4 | 3 | 2.3% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $26.5K | 1 | 1 | 0.2% |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $0 | 1 | 1 | 0.0% |
| 541690 | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES | -$2 | 1 | 1 | 0.0% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | -$15.4K | 1 | 1 | -0.1% |
08 / Buying Pattern
How does the government buy in PSC AN95?
| Common action type | Obligations | Actions |
|---|---|---|
| DEFINITIVE CONTRACT | $11.95M | 51 |
| DELIVERY ORDER | $1.70M | 17 |
| PURCHASE ORDER | $224.4K | 9 |
| BPA CALL | -$127.0K | 8 |
09 / Recent Contract Awards
What was awarded most recently in PSC AN95?
| Award / PIID | Vendor | Signed date | Obligation | NAICS | Agency / office |
|---|---|---|---|---|---|
| W81XWH20C0088 | VASCULAR SOLUTIONS LLC | Sep 8, 2025 | $0 | 541715 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
| W81XWH20C0088 | VASCULAR SOLUTIONS LLC | Feb 20, 2025 | $533.6K | 541715 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
| W81XWH20C0100 | TEVA PHARMACEUTICALS USA, INC. | Jan 22, 2025 | -$40.8K | 325412 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
| W81XWH13C0115 | SA PHOTONICS, INC. | Jan 10, 2025 | -$17.3K | 541712 | DEPT OF THE ARMYW4PZ USA MED RSCH ACQUIS ACT |
| W81XWH20C0088 | VASCULAR SOLUTIONS LLC | Oct 24, 2024 | $0 | 541715 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
10 / Market Interpretation
How should contractors evaluate this market?
Start with the spending direction
Compare annual obligations with actions and vendor participation. Growth driven by only a few large actions represents a different opportunity from broad, recurring demand.
Follow the actual buyers
Move from federal customers to contracting offices. Offices reveal where acquisition responsibility and recurring purchasing activity are concentrated.
Measure accessible demand
Use competition, small-business participation, incumbent vendors, and PSC mix before treating the full $13.74M market as addressable.